Back

Synmosa Biopharma August revenue rises nearly 50% year-on-year to NT$754 million

Verifying
  • Synmosa Biopharma reported August consolidated revenue of NT$754 million.
  • First-eight-month revenue reached NT$5.096 billion, up 25.5% year-on-year.
  • Synmosa completed Vietnam distribution partnerships and passed Japan's PMDA inspection.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.